These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers. Ishikawa K, Segawa T, Hagiwara Y, Maeda M, Abe M, Hino O. Pathol Int; 2009 Mar; 59(3):161-6. PubMed ID: 19261093 [Abstract] [Full Text] [Related]
15. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P. Clin Cancer Res; 2007 May 15; 13(10):2928-35. PubMed ID: 17504993 [Abstract] [Full Text] [Related]
17. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Shiomi K, Hagiwara Y, Sonoue K, Segawa T, Miyashita K, Maeda M, Izumi H, Masuda K, Hirabayashi M, Moroboshi T, Yoshiyama T, Ishida A, Natori Y, Inoue A, Kobayashi M, Sakao Y, Miyamoto H, Takahashi K, Hino O. Clin Cancer Res; 2008 Mar 01; 14(5):1431-7. PubMed ID: 18316566 [Abstract] [Full Text] [Related]
18. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Attanoos RL, Gibbs AR. Histopathology; 2008 Sep 01; 53(3):340-4. PubMed ID: 18647189 [Abstract] [Full Text] [Related]
19. [Malignant fibrous mesothelioma and granulomas]. Esquirol Puig X, Vilaseca Bellsolà J, Pujol Ribó J. Med Clin (Barc); 1989 Feb 11; 92(5):198. PubMed ID: 2725108 [No Abstract] [Full Text] [Related]